We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Taste-Based Influenza Test Could Replace Nasal Swabs with Chewing Gum

By LabMedica International staff writers
Posted on 07 Oct 2025

Influenza is one of the most dangerous infectious diseases worldwide, claiming around half a million lives each year. More...

What makes it particularly insidious is that flu viruses are contagious even before the first symptoms appear. Yet, diagnostic options are often expensive, complicated to use, and unavailable in many poorer regions. Now, a new, very simple self-test in the form of chewing gum or a lollipop could detect infection within minutes by producing a recognizable taste when an active virus is present.

This rapid test, developed by researchers at the University of Würzburg (Würzburg, Germany), is based on a diagnostic principle that combines a sensor molecule (thymol, a natural flavor carrier) with a virus-specific recognition component so that active influenza viruses trigger release of the flavor in saliva. The method is flexible: flavor carrier and recognition component can be swapped (sweet, bitter, or salty flavors and alternative pathogen-specific building blocks), and the group envisions delivery formats such as chewing gum or lollipops that require no laboratory, electricity, or medical personnel.

In an experimental study, clinical samples were collected and documented by hospital teams while investigations on influenza virus particles were carried out in partner labs to validate the sensor concept. The proof-of-concept work, published in ACS Central Science, shows that contact between active influenza viruses and the neuraminidase-specific sensor releases the flavoring molecule, producing a clearly recognizable taste in infected mouths but not in uninfected controls. as.

The researchers are now working on incorporating the sensors into chewing gum or lollipops and adapting the system for mass production, a process they estimate will take about four years. They believe such low-threshold diagnostics would be particularly suitable for critical locations such as schools, nurseries, and retirement homes, and could be crucial in poorer countries for outbreak control. In the longer term, they envisage voluntary reporting via a smartphone app to map spread in real time and the use of artificial intelligence (AI) to predict where epidemics or pandemics might develop.

“Instead of relying on expensive and complicated testing procedures, we use the natural human sensory system – taste – as a tool for the early detection of infections,” said Professor Lorenz Meinel, who led the study. “This strategy opens up new possibilities for the early detection and control of influenza worldwide.”

Related Links:
University of Würzburg


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Guardant Health has introduced new applications for Guardant360 Liquid, expanding the test’s capabilities for treatment selection in breast and lung cancers. (Photo courtesy of Guardant Health)

Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations

Treatment selection in advanced breast and lung cancers can be challenging when traditional biomarkers are absent and genomic findings alone do not fully clarify which therapies may be effective.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.